BDBM703971 (R)-6-amino-N-((5-bromopyridin- 2-yl)methyl)-7-methyl-N-(1- (pyrimidin-2-yl)ethyl)-1,5- naphthyridine-3-carboxamide LCMS [M + 1]+ = 480.0. 1H NMR (400 MHz, MeOD-d4) $#948; = 8.85- 8.45 (m, 4H), 8.22-8.00 (m, 1H), 7.98-7.76 (m, 2H), 7.46-7.20 (m, 2H), 5.95-5.23 (m, 1H), 4.98 (br d, J = 16.4 Hz, 1H), 4.63 (br d, J = 16.4 Hz, 1H), 2.38 (br s, 3H), 1.70 (d, J = 7.2 Hz, 3H)::US20240368153, Example 10-8
SMILES Cc1cc2ncc(C(=O)N(Cc3ccc(Br)cn3)[C@H](C)c3ncccn3)cc2nc1N
InChI Key InChIKey=DPKMKUVJFYPCMO-UHFFFAOYSA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 703971
TargetProtein arginine N-methyltransferase 5 (PRMT5) and Methylosome protein WDR77 (MEP-50)(Human)
Mirati Therapeutics
US Patent
Mirati Therapeutics
US Patent
Affinity DataIC50: 60.2nMAssay Description:Table B2: The assay uses recombinant full-length histone H2A as the PRMT5 substrate. Enzymatic transfer of the tritiated methyl group from S-adenosyl...More data for this Ligand-Target Pair
